Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinta Mizuno

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Journal of Crohn'S & Colitis|July 29, 2016
Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative ColitisShinichiro Shinzaki, Katsuyoshi Matsuoka, Hideki Iijima, et al.
World Journal of Gastrointestinal Endoscopy|June 18, 2019
Endoscopic characteristics of small intestinal malignant tumors observed by balloon-assisted enteroscopyTomofumi Horie, Naoki Hosoe, Kaoru Takabayashi, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 5, 2018
Toll-Like Receptor 7 Agonist-Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune CellsHiroki Kiyohara, Tomohisa Sujino, Toshiaki Teratani, et al.
Cell Reports|August 17, 2017
Intestinal Dysbiosis and Biotin Deprivation Induce Alopecia through Overgrowth of Lactobacillus murinus in MiceAtsushi Hayashi, Yohei Mikami, Kentaro Miyamoto, et al.
Plos One|October 5, 2018
Factors predicting the therapeutic response to infliximab during maintenance therapy in Japanese patients with Crohn's diseaseKatsuyoshi Matsuoka, Shunsuke Hamada, Mikiko Shimizu, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 12, 2019
Pharmacological effects of TAK-828F: an orally available RORγt inverse agonist, in mouse colitis model and human blood cells of inflammatory bowel diseaseKeiko Igaki, Yoshiki Nakamura, Masayuki Tanaka, et al.
Gut and Liver|December 11, 2019
Efficacy of Novel Ultrathin Single-Balloon Enteroscopy for Crohn's Disease: A Propensity Score-Matched StudyKaoru Takabayashi, Naoki Hosoe, Motohiko Kato, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 29, 2019
Factors contributing to the systemic clearance of infliximab with long-term administration in Japanese patients with Crohn's disease: Analysis using population pharmacokinetics
Katsuyoshi Matsuoka, Shunsuke Hamada, Mikiko Shimizu, et al.
Inflammatory Bowel Diseases|July 4, 2014
Cross-talk between RORγt+ innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production in Crohn's diseaseShinta Mizuno, Yohei Mikami, Nobuhiko Kamada, et al.
Intestinal Research|February 5, 2020
5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitisShinta Mizuno, Keiko Ono, Yohei Mikami, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Journal of Crohn'S & Colitis|July 29, 2016
Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative ColitisShinichiro Shinzaki, Katsuyoshi Matsuoka, Hideki Iijima, et al.
World Journal of Gastrointestinal Endoscopy|June 18, 2019
Endoscopic characteristics of small intestinal malignant tumors observed by balloon-assisted enteroscopyTomofumi Horie, Naoki Hosoe, Kaoru Takabayashi, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 5, 2018
Toll-Like Receptor 7 Agonist-Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune CellsHiroki Kiyohara, Tomohisa Sujino, Toshiaki Teratani, et al.
Cell Reports|August 17, 2017
Intestinal Dysbiosis and Biotin Deprivation Induce Alopecia through Overgrowth of Lactobacillus murinus in MiceAtsushi Hayashi, Yohei Mikami, Kentaro Miyamoto, et al.
Plos One|October 5, 2018
Factors predicting the therapeutic response to infliximab during maintenance therapy in Japanese patients with Crohn's diseaseKatsuyoshi Matsuoka, Shunsuke Hamada, Mikiko Shimizu, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 12, 2019
Pharmacological effects of TAK-828F: an orally available RORγt inverse agonist, in mouse colitis model and human blood cells of inflammatory bowel diseaseKeiko Igaki, Yoshiki Nakamura, Masayuki Tanaka, et al.
Gut and Liver|December 11, 2019
Efficacy of Novel Ultrathin Single-Balloon Enteroscopy for Crohn's Disease: A Propensity Score-Matched StudyKaoru Takabayashi, Naoki Hosoe, Motohiko Kato, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 29, 2019
Factors contributing to the systemic clearance of infliximab with long-term administration in Japanese patients with Crohn's disease: Analysis using population pharmacokinetics
Katsuyoshi Matsuoka, Shunsuke Hamada, Mikiko Shimizu, et al.
Inflammatory Bowel Diseases|July 4, 2014
Cross-talk between RORγt+ innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production in Crohn's diseaseShinta Mizuno, Yohei Mikami, Nobuhiko Kamada, et al.
Intestinal Research|February 5, 2020
5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitisShinta Mizuno, Keiko Ono, Yohei Mikami, et al.
Pageof 6